Antitumor activity and safety of pembrolizumab in patients with advanced recurrent ovarian cancer: results from the phase II KEYNOTE-100 study
Titel:
Antitumor activity and safety of pembrolizumab in patients with advanced recurrent ovarian cancer: results from the phase II KEYNOTE-100 study
Auteur:
Matulonis, U.A. Shapira-Frommer, R. Santin, A.D. Lisyanskaya, A.S. Pignata, S. Vergote, I. Raspagliesi, F. Sonke, G.S. Birrer, M. Provencher, D.M. Sehouli, J. Colombo, N. González-Martín, A. Oaknin, A. Ottevanger, P.B. Rudaitis, V. Katchar, K. Wu, H. Keefe, S. Ruman, J. Ledermann, J.A.